摘要
微生物新药的产业化和高效制造是国家重大需求。然而天然产物作为次级代谢产物并非微生物生存所必需,以生存为目标的自然演化使微生物只在营养困乏期或者应激反应时才精确调控少量产生。尽管大量次级代谢产物的生物合成途径都得到了阐明,但初级代谢和次级代谢之间的转换机制仍不清楚,已成为制约细胞工厂高效生物制造药物的瓶颈。建立合成生物学5M策略和活细胞代谢实时监测工具是解决该科学问题的关键。本文聚焦链霉菌聚酮类化合物代谢转换机制的研究和智能制造,利用开发的系列特异性监测NAD(H)、NADP(H)的遗传编码荧光探针,详细解析了链霉菌胞内三酰甘油(TAGs)的降解机制,通过设计符合原子经济性原则的产物生物合成途径、动态精细调控等策略大幅度提高几种聚酮类药物(actinorhodin,jadomycin B和oxytetracycline)产量,其中阿维菌素B1a的工业生产效价提高了50%以上,达到有史以来最高的效价。
Industrialization and efficient manufacturing of new microbial drugs is a major national interest.However,secondary metabolites are not indispensable for the survival evolution of those microorganisms.Only small amounts of natural products are tightly produced under stress or shortage of food.Pharmaceutically important polyketides such as avermectin are mainly produced as secondary metabolites during the stationary phase growth of Streptomyces species in bioreactors.The source of intracellular metabolites that are funneled into polyketide biosynthesis has proven elusive.We applied 5 M strategy and real time biosensors for living cell metabolism.The intracellular triacylglycerols(TAGs),which accumulates in primary metabolism,are degraded during stationary phase.This process could redirect the carbon flux from both intracellular TAGs and extracellular substrates into polyketide biosynthesis.We devised a strategy named‘dynamic degradation of TAG’(ddTAG)to mobilize the TAG pool and increase polyketide biosynthesis.Using dd TAG we increased the titers of actinorhodin,jadomycin B,oxytetracycline and avermectin B1a in Streptomyces coelicolor,Streptomyces venezuelae,Streptomyces rimosus and Streptomyces avermitilis.Application of dd TAG increased the titer of avermectin B1a by 50%in a 180 m3 industrial-scale fermentation,which is the highest titer ever reported.Our strategy provides new ideas for intelligent biomanufacturing of polyketides and other types of secondary metabolites.Series of work are well received and published in Nat Biotech(article),Nat Methods,Nucleic Acids Res,and etc.
作者
张立新
杨弋
赵玉政
王为善
郑俊克
李珊珊
陈显军
张敬宇
刘雪婷
谭高翼
Zhang Lixin;Yang Yi;Zhao Yuzheng;Wang Weishan;Zheng Junke;Li Shanshan;Chen Xianjun;Zhang Jingyu;Liu Xueting;Tan Gaoyi(State Key Laboratory of Bioreactor Engineering,School of Biotechnology,East China University of Science and Technology,Shanghai 200237;State Key Laboratory of Microbial Resources and CAS Key Laboratory of Pathogenic Microbiology and Immunology,Institute of Microbiology,Chinese Academy of Sciences,Beijing 100101;School of basic medicine,Shanghai Jiaotong University,Shanghai 200025;State Key Laboratory for Biology of Plant Diseases and Insect Pests,Institute of Plant Protection,Chinese Academy of Agricultural Sciences,Beijing 100193)
出处
《中国基础科学》
2020年第6期1-9,共9页
China Basic Science
基金
国家重点研发计划(项目:2019YFA0906200,课题:2020YFA090032)
国家自然科学基金项目(21877038,81903529,31720103901,81573341)
上海市科学技术委员会基础研究项目(18JC1411900)
上海市青年科技启明星计划(20QA1402800)
高等学校学科创新引智计划(B18022)
生物反应器工程国家重点实验室开放课题
关键词
智能生物制造
聚酮
阿维菌素B1a
代谢调控
荧光探针
intelligent bio-manufacture
polyketides
avermectin B1a
metabolic regulation
fluorescent probe